# ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO

> **NCT03563417** · NA · RECRUITING · sponsor: **Aarhus University Hospital Skejby** · enrollment: 1560 (estimated)

## Conditions studied

- Ischemic Heart Disease
- Chronic Total Occlusion of Coronary Artery

## Interventions

- **PROCEDURE:** Percuteneous Coronary Intervention
- **OTHER:** Optimal Medical Therapy

## Key facts

- **NCT ID:** NCT03563417
- **Lead sponsor:** Aarhus University Hospital Skejby
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-11-06
- **Primary completion:** 2028-11-01
- **Final completion:** 2032-11-01
- **Target enrollment:** 1560 (ESTIMATED)
- **Last updated:** 2026-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03563417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03563417, "ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03563417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*